Autori: Molden Espen
Naslov | A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram (Article) |
Autori | Braten Line Skute Haslemo Tore Jukic Marin M Ivanov Maxim Ingelman-Sundberg Magnus Molden Espen Kringen Marianne Kristiansen |
Info | CLINICAL PHARMACOLOGY & THERAPEUTICS, (2021), vol. 110 br. 3, str. 786-793 |
Projekat | South-Eastern Norway Regional Health Authority; Diakonhjemmet Hospital found for research, innovation, and professional development; European Commission [668353] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders (Article) |
Autori | Smith Robert Lovsletten Tveito Marit Kylleso Lennart Jukic Marin M Ingelman-Sundberg Magnus Andreassen Ole A Molden Espen |
Info | SCHIZOPHRENIA RESEARCH, (2021), vol. 228 br. , str. 590-596 |
Projekat | South-Eastern Norway Regional Health Authority, Hamar, Norway [2016097, 2017085]; Research Council of Norway, Oslo, NorwayResearch Council of Norway [223273]; H2020 program U-PGx, Stockholm, Sweden [668353]; Swedish Research Council, Stockholm, SwedenSwed |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure A Systematic Review and Meta-analysis (Review) |
Autori | Milosavljevic Filip Bukvic Nikola Pavlovic Zorana Z Miljevic Cedo D Pesic Vesna Molden Espen Ingelman-Sundberg Magnus Leucht Stefan Jukic Marin M |
Info | JAMA PSYCHIATRY, (2021), vol. 78 br. 3, str. 270-280 |
Projekat | Science Fund of the Republic of Serbia PROMIS program [6066800/PsyCise]; Swedish Research Council [2015-02760]; European Union (EU) [668353/U-PGx]; Swedish Brain foundation [FO2019-0260] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis (Meeting Abstract) |
Autori | Milosavljevic Filip Bukvic Nikola Pavlovic Zorana Z Miljevic Cedo D Pesic Vesna Molden Espen Ingelman-Sundberg Magnus Leucht Stefan Jukic Marin M |
Info | EUROPEAN NEUROPSYCHOPHARMACOLOGY, (2020), vol. 40 br. , Suppl. 1, str. S250-S251 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs & ndash; A study based on blood sample analyses from 24,239 patients (Article) |
Autori | Smith Robert Lovsletten Tveito Marit Kylleso Lennart Jukic Marin M Ingelman-Sundberg Magnus Andreassen Ole A Molden Espen |
Info | EUROPEAN NEUROPSYCHOPHARMACOLOGY, (2020), vol. 37 br. , str. 64-69 |
Projekat | South-Eastern Norway Regional Health Authority [2016097, 2017085]; Research Council of NorwayResearch Council of Norway [223273]; H2020 program U-PGx [668353]; Swedish Research Council [2015-02760]; Swedish Brain foundation |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients (Article) |
Autori | Braten Line Skute Haslemo Tore Jukic Marin M Ingelman-Sundberg Magnus Molden Espen Kringen Marianne Kristiansen |
Info | NEUROPSYCHOPHARMACOLOGY, (2020), vol. 45 br. 3, str. 570-576 |
Projekat | South-Eastern Norway Regional Health Authority |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Quantification of antidepressant and antipsychotic exposure increase caused by CYP2C19 and CYP2D6 intermediate and poor metabolizer status by meta-analysis (Meeting Abstract) |
Autori | Milosavljevic Filip Bukvic Nikola Pesic Vesna Molden Espen Ingelman-Sundberg Magnus Jukic Marin M |
Info | EUROPEAN NEUROPSYCHOPHARMACOLOGY, (2019), vol. 29 br. , Suppl. 6, str. S533-S534 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study (Article) |
Autori | Jukic Marin M Smith Robert Lovsletten Haslemo Tore Molden Espen Ingelman-Sundberg Magnus |
Info | LANCET PSYCHIATRY, (2019), vol. 6 br. 5, str. 418-426 |
Projekat | Swedish Research Council [2015-02760]; European Union's Horizon 2020 research and innovation program U-PGx [668353]; Swedish Brain foundation [FO2017-0111]; South-Eastern Norway Regional Health Authority [2016-097] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients (Article) |
Autori | Haslemo Tore Eliasson Erik Jukic Marin M Ingelman-Sundberg Magnus Molden Espen |
Info | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, (2019), vol. 85 br. 1, str. 194-201 |
Projekat | Swedish Research Council [2016-01153, 2015-02760, 2016-01154]; The European Union's Horizon 2020 research and innovation program U-PGx [668353] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients (Article) |
Autori | Jukic Marin M Haslemo Tore Molden Espen Ingelman-Sundberg Magnus |
Info | AMERICAN JOURNAL OF PSYCHIATRY, (2018), vol. 175 br. 5, str. 463-470 |
Projekat | Swedish Research Council [2015-02760]; European Union [668353]; Swedish Brain foundation [FO2015-0235]; South-Eastern Norway Regional Health Authority [2016-097] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|